BeyondSpring Files 2023 Annual Report on Form 20-F
FLORHAM PARK, N.J., April 29, 2024 -- BeyondSpring Inc. , a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it has filed its...